Autonomous Navigation
Robotic autonomy for safer, more precise screening, diagnosis, and intervention.
Beyond vision
Intelligent GI
Endoscopy.
EndoHaptix is developing the next generation of robotic upper and lower gastrointestinal endoscopy by combining robotics, autonomy, tactile sensing, and multimodal AI for earlier detection and more informed diagnosis.
TactileTexture and stiffness
MultimodalVision and touch
Artificial IntelligenceInterpretation and insight
RoboticsPrecision and control
Why it matters
Endoscopy can see the surface. Disease does not always announce itself visually.
Conventional endoscopy depends on manual scope control and vision-based assessment, making procedures challenging and highly operator dependent. EndoHaptix integrates robotics, autonomy, tactile sensing, and multimodal AI to make endoscopy more intelligent, more consistent, and more informative.
Beyond appearance
Palpation measures how tissue responds to controlled contact, adding information that a camera alone cannot provide.
Diagnostic insight
Texture, stiffness and compliance create a mechanical signature designed to support diagnosis, not detection alone.
Repeatable mapping
Spatial measurements can map a region of interest and support repeatable access and longitudinal comparison.
The EndoHaptix platform
Two technologies. One intelligent platform.
A unified platform combining robotics and intelligent autonomy with tactile sensing and multimodal AI to help clinicians navigate with greater precision, feel tissue mechanics, understand disease, and make more informed decisions.
Robotic Autonomy
Transforming navigation and intervention through intelligent robotics.
Robotic control and intelligent autonomy assist clinicians with precise navigation, stable scope control, and dexterous therapeutic intervention. Designed to improve procedural safety, reduce operator burden, and enable more consistent procedures, including polypectomy, biopsy, and other minimally invasive endoscopic therapies.
Visual–Tactile Intelligence
Combining vision and touch for a deeper understanding of disease.
Multimodal AI fuses endoscopic imaging with high-resolution tactile sensing to identify, characterize, and map abnormalities that may not be apparent through vision alone, providing clinicians with richer, more actionable insights for diagnosis and intervention.
Clinical focus
Focused on gastrointestinal diseases.
The platform is being developed for upper and lower GI applications where visual information alone may not provide the complete picture.
- Colorectal cancer
- Upper GI cancer
- Crohn's disease
- Ulcerative colitis
- Inflammatory bowel disease
- Polyps and precancerous lesions
Our team
Leadership and clinical expertise.
Expertise across company building, surgical robotics, intelligent endoscopy, medical devices, and clinical translation.
CEO
Sara Mitran
Sara leads company strategy, commercialization, and the development of EndoHaptix.
View profile
Founder-CTO
Mohsen Khadem
Mohsen contributes expertise in surgical robotics, interventional robotic platforms, and intelligent autonomy.
View profile
CMO
Joga Ivatury, M.D., MHA
Joga guides clinical strategy with expertise in colorectal cancer, inflammatory bowel disease, and advanced colon and rectal surgery.
View profile
Founder - Technical Advisor
Farshid Beigi
Farshid brings expertise in surgical robotics, haptic and tactile sensing, intelligent systems, and dexterous intervention.
View profileBeyond vision
Advancing intelligent GI endoscopy.
We welcome conversations with gastroenterologists, researchers, engineers, strategic partners and investors advancing tactile sensing and multimodal AI in endoscopy.
info@endohaptics.com